6
Views
9
CrossRef citations to date
0
Altmetric
Original Article

New Method to Quantitate Platelets Adhered on Biomaterials Using Monoclonal Antibodies to Human Platelet Membrane Glycoprotein SZ-21

, , , , , & show all
Pages 423-435 | Published online: 11 Jul 2009
 

Abstract

This study developed a new technique to quantitate platelets adhered on biomaterials surfaces in vitro, based on a surface phase radioimmunoassay using a monoclonal antidoby SZ-21, directed specifically against the membrane glycoprotein complex IIIa of human platelets. In vitro perfusion is performed in system which consists of testing tubes and infusion pump. After 5 minutes perfusion with fresh ACD anticoagulated human whole blood at 2,000s-1 platelets deposition on surface precoated with proteins determined using anti-human platelet antibody (125 I-SZ-21) are 4,173 ± 932 (Albumin), 59,032 ± 25,554 (Fibrinogen), and 71,253 ± 11,484 (Collagen). Meanwhile, platelets adhered on surfaces of four polymers were determined (platelet/mm2): 19,493 ± 2,050 (Silicone), 48,193 ± 4,055 (Polytetraflyuoroethylene), 50,375 ± 8,675 (Polyvinyl chloride) and 101,906 ± 5,916 (Polyethylene). These results were confirmed by SEM. This method is not only applied for evaluating rapidly and reliably blood compatibility of biomaterials in vitro, but will be used at basic study for interaction of blood materials.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.